Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans
- PMID: 4330997
- DOI: 10.1093/infdis/124.2.148
Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans
Similar articles
-
Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.J Infect Dis. 1971 Aug;124(2):155-60. doi: 10.1093/infdis/124.2.155. J Infect Dis. 1971. PMID: 4330998 Clinical Trial. No abstract available.
-
Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines.Am J Epidemiol. 1971 Aug;94(2):142-6. doi: 10.1093/oxfordjournals.aje.a121306. Am J Epidemiol. 1971. PMID: 4327997 No abstract available.
-
Immunization of Canadian Armed Forces personnel with live types 4 and 7 adenovirus vaccines.Can J Public Health. 1986 Sep-Oct;77(5):367-70. Can J Public Health. 1986. PMID: 3024797 Clinical Trial. No abstract available.
-
Current use and future directions of adenovirus vaccine.Semin Respir Infect. 1989 Dec;4(4):299-303. Semin Respir Infect. 1989. PMID: 2560582 Review.
-
Immunization against respiratory virus infections.Mod Trends Immunol. 1967;2:53-85. Mod Trends Immunol. 1967. PMID: 4298139 Review. No abstract available.
Cited by
-
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.J Virol. 2022 Jan 26;96(2):e0159921. doi: 10.1128/JVI.01599-21. Epub 2021 Oct 27. J Virol. 2022. PMID: 34705557 Free PMC article.
-
Construction of an adenovirus type 7a E1A- vector.J Virol. 1997 Nov;71(11):8946-51. doi: 10.1128/JVI.71.11.8946-8951.1997. J Virol. 1997. PMID: 9343264 Free PMC article.
-
A Phase 1 Two-Arm, Randomized, Double-Blind, Active-Controlled Study of Live, Oral Plasmid-Derived Adenovirus Type 4 and Type 7 Vaccines in Seronegative Adults.Vaccines (Basel). 2023 Jun 12;11(6):1091. doi: 10.3390/vaccines11061091. Vaccines (Basel). 2023. PMID: 37376480 Free PMC article.
-
Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin.PLoS One. 2012;7(2):e31177. doi: 10.1371/journal.pone.0031177. Epub 2012 Feb 17. PLoS One. 2012. PMID: 22363572 Free PMC article.
-
Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention.Semin Respir Crit Care Med. 2016 Aug;37(4):586-602. doi: 10.1055/s-0036-1584923. Epub 2016 Aug 3. Semin Respir Crit Care Med. 2016. PMID: 27486739 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical